| adapt health locations |
|
|
28 |
|
♡
|
| antimicrobial |
|
|
3 |
|
♡
|
| pneumocystis pneumonia |
|
|
18 |
|
♡
|
| clinical practice guidelines |
|
|
90 |
|
♡
|
| antimicrobial resistance |
|
|
5 |
|
♡
|
| VIPONLYVIPONL VIPONLYVIPO |
|
|
7 |
|
♡
|
| VIPONLYVIP NLY IPONLYVIPONLY IPONLYVI |
|
|
6 |
|
♡
|
| VIPO LYVIPONLYVIPO LYVIPONLYV |
|
|
8 |
|
♡
|
| VIPONLYVIPONL VIPONLYV |
|
|
4 |
|
♡
|
| VIPONLY IP NLYVIPONLYVIP NLYVIPONLYVI |
|
|
3 |
|
♡
|
| VIP NLYVIPON |
|
|
92 |
|
♡
|
| VIPONL VIPONL VIPONLYVIP |
|
|
91 |
|
♡
|
| VIP |
|
|
35 |
|
♡
|
| VI ONLYVI ONLY |
|
|
15 |
|
♡
|
| VIPONLYVIP NLYVIPON |
|
|
19 |
|
♡
|
| VIP NLYVIPONLY IPONLYVI |
|
|
20 |
|
♡
|
| VIPONLYVIP NLYVIPO |
|
|
19 |
|
♡
|
| VIPONLYV PONLYVIPON YVIPONLY |
|
|
32 |
|
♡
|
| VIPONLYVIP |
|
|
23 |
|
♡
|
| VIPONLY IP NLYVIPONLY IPONLYVI |
|
|
9 |
|
♡
|